Kolexia
Moreau Lionel Pneumologie
Moreau Lionel
Pneumologie
Hôpital Louis Pasteur Colmar
Colmar, France
74 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Adénocarcinome Carcinome épidermoïde Carcinomes Adénocarcinome bronchioloalvéolaire Carcinome à grandes cellules Tumeurs du cerveau

Collaborateurs

Voir plus
Debieuvre Didier
Debieuvre Didier
Hôpital Emile Muller, Mulhouse, France
Moro-Sibilot Denis
Moro-Sibilot Denis
Hôpital Nord Grenoble, La Tronche, France
Neidhardt Anne-Catherine
Neidhardt Anne-Catherine
Hôpital Louis Pasteur Colmar, Colmar, France
Oster Jean-Philippe
Oster Jean-Philippe
Hôpital Louis Pasteur Colmar, Colmar, France

Industries

Voir plus
A+A
6 collaboration(s)
Dernière en 2023
AstraZeneca
6 collaboration(s)
Dernière en 2023
IQVIA
3 collaboration(s)
Dernière en 2022
Pfizer
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ROSIE: A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   06 mars 2024
TAXIO: A Phase II Study Assessing the Efficacy of Etoposide Free Chemotherapy Plus Durvalumab (MEDI4736) in First Line Extensive Disease Small Cell Lung Cancer (SCLC)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   18 décembre 2023
2026P Small cell lung cancer (SCLC) in the KBP-2020-CPHG cohort and comparison with 2000 and 2010
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
BioCAST: French Biological Observatory on Lung Cancer in Never Smokers
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   22 mai 2023
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
Essai Clinique (CHU Strasbourg)   18 novembre 2022
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
The Lancet regional health. Europe   29 août 2022
132P 20 years of real life nationwide epidemiological data on lung cancer in non-academic French public hospitals: KBP-2020-CPHG compared to 2000 and 2010 studies
European Lung Cancer Congress (ELCC) 2022, 30 March-2 April 2022   01 avril 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   05 mars 2022
Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial.
Lung cancer (Amsterdam, Netherlands)   30 novembre 2021
1202P ALK-2016-CPHG: French cohort of advanced non-small cell lung cancer (aNSCLC) with ALK (ALK+) or ROS1 (ROS1+) gene rearrangement treated by crizotinib
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021